About
Van Zyl holds a degree in medical biochemistry from the University of Cape Town. Lundbeck's biography says he has more than 23 years of international commercial experience in pharmaceuticals. His earlier roles included Business Unit Manager at Eli Lilly, Head of Marketing and Sales at Novartis Pharma, CEO of JADO Technologies, a corporate vice president role at Bausch & Lomb, an executive vice president role at BSN Medical, and a senior role at UCB leading its neurology business. UCB is led by Jean-Christophe Tellier. Another pharmaceutical leader on Whoo is Mike Doustdar of Novo Nordisk, also a Danish company.
Whoo compiled this page from public sources: Lundbeck executive management, Wikipedia, Zonebourse. It is not affiliated with or endorsed by Charl van Zyl. Are you Charl van Zyl? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.
Want a page like this? Create yours from your résumé.
Experience
President and CEO — Lundbeck
2023 – Present
- Leads the Executive Leadership Team
- Senior role at UCB before moving to Lundbeck, overseeing neurology globally